UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:November 18,
AVEO Pharmaceuticals (NASDAQ:AVEO)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more AVEO Pharmaceuticals Charts.
AVEO Pharmaceuticals (NASDAQ:AVEO)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more AVEO Pharmaceuticals Charts.

Aveo Pharmaceuticals, Inc. News

CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
Friday 29 March 2024 (1 month ago) • GlobeNewswire Inc.
AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
Monday 25 March 2024 (1 month ago) • GlobeNewswire Inc.
AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial in The Oncologist
Wednesday 7 February 2024 (3 months ago) • GlobeNewswire Inc.
AVEO Oncology Enrolls First Patient in Pivotal FIERCE-HN Clinical Trial to Evaluate Ficlatuzumab in Combination with ERBITUX® (cetuximab) in Patients with HPV-negative Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
Tuesday 16 January 2024 (4 months ago) • GlobeNewswire Inc.

More Aveo Pharmaceuticals, Inc. News Articles